blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3860571

EP3860571 - TREATING ESSENTIAL TREMOR USING (R)-2-(4-ISOPROPYLPHENYL)-N-(1-(5-(2,2,2-TRIFLUOROETHOXY)PYRIDIN-2-YL)ETHYL)ACETAMIDE [Right-click to bookmark this link]
StatusExamination is in progress
Status updated on  18.07.2024
Database last updated on 25.09.2024
FormerRequest for examination was made
Status updated on  09.07.2021
FormerThe international publication has been made
Status updated on  11.04.2020
Most recent event   Tooltip30.08.2024New entry: Renewal fee paid 
Applicant(s)For all designated states
Cavion, Inc.
600 East Water Street, Suite E
Charlottesville, VA 22902 / US
[2021/32]
Inventor(s)01 / LEE, Margaret S.
20 Pleasant Street
Middleton, Massachusetts 01949 / US
02 / PAPAPETROPOULOS, Spyridon
22 Skyline Drive
Wellesley, Massachusetts 02482 / US
03 / HIGGIN, Michelle S.
5516 Solomon's Seal Court
Holly Springs, North Carolina 27540 / US
04 / DUVVURI, Muralikrishna
104 Bristol Drive
Chapel Hill, North Carolina 27516 / US
05 / REHLAENDER, Bruce N.
15100 Weston Parkway, Suite 101
Cary, North Carolina 27513 / US
06 / NEWBOLD, Evan
910 Rainier Road
Charlottesville, Virginia 22903 / US
 [2021/32]
Representative(s)Carpmaels & Ransford LLP
One Southampton Row
London WC1B 5HA / GB
[2021/32]
Application number, filing date19868543.003.10.2019
[2021/32]
WO2019US54498
Priority number, dateUS201862740755P03.10.2018         Original published format: US 201862740755 P
US201862780049P14.12.2018         Original published format: US 201862780049 P
[2021/32]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2020072773
Date:09.04.2020
Language:EN
[2020/15]
Type: A1 Application with search report 
No.:EP3860571
Date:11.08.2021
Language:EN
The application published by WIPO in one of the EPO official languages on 09.04.2020 takes the place of the publication of the European patent application.
[2021/32]
Search report(s)International search report - published on:US09.04.2020
(Supplementary) European search report - dispatched on:EP31.05.2022
ClassificationIPC:A61K9/14, A61K9/16, A61K9/48
[2021/32]
CPC:
A61K9/1652 (EP,IL,KR); A61K9/0053 (KR,US); A61K31/4412 (EP,IL,KR,US);
A61K31/44 (US); A61K9/0095 (KR); A61K9/4808 (KR);
A61K9/4816 (KR); A61K9/5026 (EP,IL,KR); A61P25/08 (US);
A61P25/14 (EP,IL,KR,US); A61P25/16 (US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2021/32]
TitleGerman:BEHANDLUNG VON ESSENTIELLEM TREMOR UNTER VERWENDUNG VON (R)-2-(4-ISOPROPYLPHENYL)-N-(1-(5-(2,2,2-TRIFLUORETHOXY)PYRIDIN-2-YL)ETHYL)ACETAMID[2021/32]
English:TREATING ESSENTIAL TREMOR USING (R)-2-(4-ISOPROPYLPHENYL)-N-(1-(5-(2,2,2-TRIFLUOROETHOXY)PYRIDIN-2-YL)ETHYL)ACETAMIDE[2021/32]
French:TRAITEMENT DES TREMBLEMENTS ESSENTIELS À L'AIDE DE (R)-2-(4-ISOPROPYLPHÉNYL)-N-(1-(5-(2,2,2-TRIFLUOROÉTHOXY)PYRIDIN-2-YL)ÉTHYL)ACÉTAMIDE[2021/32]
Entry into regional phase30.04.2021National basic fee paid 
30.04.2021Search fee paid 
30.04.2021Designation fee(s) paid 
30.04.2021Examination fee paid 
Examination procedure30.04.2021Examination requested  [2021/32]
22.12.2022Amendment by applicant (claims and/or description)
17.07.2024Despatch of a communication from the examining division (Time limit: M04)
Fees paidRenewal fee
29.09.2021Renewal fee patent year 03
26.08.2022Renewal fee patent year 04
29.08.2023Renewal fee patent year 05
29.08.2024Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]WO2016187718  (ODIDI ISA [CA]);
 [A]WO2017070680  (CAVION LLC [US]);
 [A]US2017189342  (NGUYEN JACK [US], et al);
International search[Y]US2004198822  (FRASER MATTHEW OLIVER [US], et al);
 [Y]US2010151022  (LENAERTS VINCENT [CA], et al);
 [Y]US2014004186  (HUSTVEDT SVEIN OLAF [NO], et al);
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.